NOVUS THERAPEUTICS INC's ticker is NVUS and the CUSIP is 67011N204. A total of 19 filers reported holding NOVUS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $1,105,000 | – | 73,650 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 167,333 | $2,577,000 | 1.97% |
| Cormorant Asset Management, LP | 1,415,500 | $21,363,000 | 0.51% |
| BVF INC/IL | 763,279 | $11,754,000 | 0.46% |
| Woodline Partners LP | 892,555 | $13,745,000 | 0.36% |
| Logos Global Management LP | 224,071 | $3,451,000 | 0.30% |
| Maven Securities LTD | 111,555 | $1,718,000 | 0.17% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 892,555 | $13,745,000 | 0.03% |
| Orbimed Advisors | 73,650 | $1,105,000 | 0.01% |
| Tower Research Capital LLC (TRC) | 2,598 | $40,000 | 0.00% |
| Renaissance Technologies | 43,251 | $666,000 | 0.00% |